Seattle University

ScholarWorks @ SeattleU
Doctor of Nursing Practice Projects

College of Nursing

2021

Implementation of a Transitional Care Pilot Program to Reduce
Heart Failure Readmissions
Kaylin Martin
Seattle University

Follow this and additional works at: https://scholarworks.seattleu.edu/dnp-projects
Part of the Nursing Commons

Recommended Citation
Martin, Kaylin, "Implementation of a Transitional Care Pilot Program to Reduce Heart Failure
Readmissions" (2021). Doctor of Nursing Practice Projects. 20.
https://scholarworks.seattleu.edu/dnp-projects/20

This Project is brought to you for free and open access by the College of Nursing at ScholarWorks @ SeattleU. It
has been accepted for inclusion in Doctor of Nursing Practice Projects by an authorized administrator of
ScholarWorks @ SeattleU.

Running head: IMPLEMENTATION OF A TRANSITIONAL CARE PILOT PROGRAM

1

Implementation of a Transitional Care Pilot Program to Reduce Heart Failure Readmissions
Kaylin Martin
Seattle University
A DNP project submitted in partial fulfillment of the requirements for the degree of

Doctor of Nursing Practice
Seattle University
March 2021

Approved by: _______________________________

3-18-2021
Date: ___________

DNP Mentor: Benjamin Miller, PhD, ARNP, FNP-C, ACNPC, ENP-C, FAANP

Approved by: __________________________________________

March 18, 2021

Date: ____________

DNP Reader: Diane Fuller Switzer, DNP, ARNP, FNP-C, ENP-C, FAEN

IMPLEMENTATION OF A TRANSITIONAL CARE PILOT PROGRAM

2

Acknowledgments
I would like to thank my project chair Dr. Benjamin Miller for extending his guidance,
resources, and firm nudge in the right direction throughout this entire process. Thank you to
Marlo Kentner, my project mentor from the healthcare organization for her never-ending support
and encouragement. Thank you to Dr. Diane Switzer my reader as well as other Seattle
University faculty for their ever-helpful insights and feedback. A huge thank you to the heart
failure clinic providers and axillary staff, without your hard work and determination for quality
patient care there would be no project to evaluate.

IMPLEMENTATION OF A TRANSITIONAL CARE PILOT PROGRAM

3

TABLE OF CONTENTS
Abstract……………………………………………………………………………………………4
Introduction………………………………………………………………………………………..5
Background and Significance……………………………………………………………………..6
Project Purpose and Aims………………………………………………………………………..12
Review of Literature …………………………………………………………………………….12
Methodology……………………………………………………………………………………..18
Results……………………………………………………………………………………………21
Discussion………………………………………………………………………………………..24
References………………………………………………………………………………………..28
Appendix A: Tables ………………………………………………………………….…….……36
Appendix B: Figures………………………...………………………………………...…………41

IMPLEMENTATION OF A TRANSITIONAL CARE PILOT PROGRAM

Abstract
Heart failure is a chronic collection of symptoms which primarily affect the elderly. The
condition requires complex care and management, which is not only taxing on the patient but
amass to large costs primarily from hospital admissions and readmissions. Readmissions are a
key measurement in heart failure as Centers for Medicare and Medicaid with the Hospital
Readmissions Reduction Program has enacted penalties to organizations with excess
readmissions. Transitional care is a collection of interventions targeted at preventing
readmissions and improving patient outcomes by early intervention and management after a
patient has been hospitalized. This project established a pilot transitional care program for a
community-based healthcare organization with an inpatient and outpatient network. Patients in
the transitional care interventions had a lower rate of readmissions compared to previous
historical data and those not enrolled in the program, indicating that while a transitional care
program requires an increase in resources the benefits have the potential to outweigh the effort.
Further studies with a larger intervention group are recommended to further evaluate the effect
on heart failure readmissions.
Keywords: Hospital readmissions, Transitional care, Pilot study
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Implementation of a Transitional Care Pilot Program
to Reduce Heart Failure Readmissions
The American Heart Association currently estimates 6.2 million individuals in the United
States experience heart failure and within 10 years this number is projected to increase by 46%
(Benjamin et al., 2019). The 5-year prognosis of heart failure is approximately 50% and patients
with the condition often experience marked decrease in the ability to perform activities of daily
life and self-reported quality of life (Benjamin et al., 2019; Rankin, Rowen, Howe, Cleland, &
Whitty, 2019). Heart failure not only has a huge impact on patients but also contributes to a
large portion of spending in the United States. By 2030 the United States is expected to spend
approximately 160 billion dollars annually on all cardiology care for patients with the condition
(Heidenreich et al., 2013).
Hospital readmissions have become an indicator for healthcare quality and a target to
address for excess costs. Due to the chronic and progressive nature of heart failure, its
complexity in the pathophysiology and pharmacological management, and the high level of
patient lifestyle modifications required; heart failure patients often have periods of acute
exacerbations resulting in high rates of hospital admissions and readmissions. Medicare has
transferred the financial burden of readmissions within 30 days to the admitting hospital through
the Hospital Readmissions Reduction Program (US Centers for Medicare and Medicaid, 2020).
Transitional care is a collection of early interventions to bridge care between an acute
hospitalization and management after discharge to reduce readmissions and improve patient
outcomes. Transitional care provides a seamless transition from the inpatient setting to
community-based care. Components of the transitional care model include: Patient education,
communication, and patient empowerment (Naylor et al., 2004; Albert, Barnanson, Deswal, &
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Hernandez, 2015;). Transitional care performed by an advanced-practice nurse has been effective
in readmission reduction and treatment adherence, but is not widely implemented (Albert,
Barnanson, Deswal, & Hernandez, 2015; Naylor et al., 2004; Naylor, 2000; Naylor et al., 2018).
Background and Significance of the Complexity of Heart Failure
Heart Failure Classifications
Two distinguishable variations of heart failure exist: Heart failure with reduced ejection
fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF). HFrEF results from
systolic dysfunction; when the heart ejects abnormally and results in a higher ventricular endsystolic volume and a reduction the left ventricular ejection fraction (Beggs, 2017, pp 20922121). HFpEF often occurs from diastolic dysfunction, a decrease in compliance during diastole
that affects ventricular filling (Beggs, 2017, pp 2092-2121). A large portion of heart failure
patients have both systolic and diastolic dysfunction (Beggs, 2017, pp 2092-2121). Most studies
have been done on heart failure patients with reduced ejection fraction and serious gaps in
knowledge exist about the etiology and proper management of individuals with preserved
ejection fraction (Van Riet et al., 2016). As the population in the US ages, the prevalence of
heart failure with preserved ejection fraction has increased and is estimated to account for fifty
percent of heart failure hospitalizations (Benjamin, et al., 2019). There is also a significant
differentiation between ischemic and non-ischemic heart failure. Ischemic heart failure roots
from an ischemic process such as coronary artery disease and/or previous myocardial infarction.
Around 30-40% of HFrEF patients are of ischemic etiology and though treatment management is
the same, ischemic heart failure has a significantly increased mortality rate and poor prognosis
when compared to nonischemic because of myocardial death versus myocardial dysfunction
(Zhang et al., 2020).
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Etiology and Epidemiology of Heart Failure
Heart failure is a syndrome of a culmination of symptoms and physiological changes
resulting from a mismatch in the body’s cardiac requirements and cardiac output. This can spur
from an acute disease process such as cardiogenic shock, but most often happens from long
standing hypertension and coronary artery disease (Mosterd & Hoes, 2007). The population with
the highest prevalence of heart failure is the elderly with around 12% of Americans over the age
of 80 diagnosed with heart failure (Mosterd & Hoes, 2007; Benjamin, et al., 2019). The lifetime
risk for heart failure in Americans 45-95 years in age ranges between 20 and 40 %, with
significant risk factors including elevated body mass index and hypertension when age is
controlled (Benjamin, et al., 2019).
Clinical Manifestations
Primary symptoms of heart failure arise from compensatory measures the body initiates
once a reduction in cardiac output is recognized. These measures lead to fluid overload,
increased sympathetic activation, and myocardial remodeling (Miller, 2021, pp 1-12). The
cardinal symptoms of heart failure are dyspnea and fatigue, and other common signs include
lower extremity or systemic edema and jugular vein distention (Beggs, 2017, pp 2092-2121).
The patient may also experience cough, orthopnea, paroxysmal nocturnal dyspnea, palpitations,
and presyncope or syncope (Beggs, 2017, pp 2092-2121).
Pathophysiology of Heart Failure
When cardiac injury causes hemodynamic changes which lower cardiac output,
compensatory neuro-hormonal changes respond to regulate cardiac output but end up enhancing
damage through cardiac remodeling. When cardiac output is compromised, blood pressure
decreases and the body attempts to compensate by increasing preload (Sayer & Bhat, 2014). The
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body achieves this by activating the renin-angiotensin- aldosterone system (RAAS) which in turn
increases water and sodium resorption. The increased blood volume increases preload and
myocardial contraction (Miller, 2021, pp 1-12). The RAAS system is counter regulated by
natriuretic peptides, however with longstanding heart failure peripheral resistance builds against
natriuretic peptides, allowing RAAS to go unopposed causing fluid overload which further
damages the heart (Harrtupe & Mann, 2017). First line heart failure treatment with angiotensin
converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs) work to limit the
effect of the RAAS pathway and prevent harmful cardiac remodeling and hypertrophy (Sayer &
Bhat, 2014). Angiotensin also initiates cardiac remodeling leading to more damage and left
ventricular dysfunction (Banasik & Kim, 2013, pp 408-418; Sayer & Bhat, 2014). Aldosterone
and angiotensin II also stimulate myofibroblast stimulation leading to myocardial fibrosis
(Harrtupe & Mann, 2017). Even when RAAS is opposed with ACEi or ARBs, in over 30% of
heart failure patient aldosterone levels continue to rise even with RAAS suppression by ACEi or
ARBs, validating the needed for aldosterone antagonists within heart failure pharmacotherapy
(Harrtupe & Mann, 2017). The fluid overload also causes systemic and pulmonary congestive
symptoms which often decrease quality of life. Diuretics assist in symptom management
resultant from volume overload (Miller, 2021, pp 1-12).
A reduction in stroke volume initiates sympathetic activation which causes increased
heart rate and contraction (Miller, 2021, pp 1-12). Longstanding sympathetic activation
increases afterload and puts added work on the heart causing a cyclic effect by further reducing
stroke volume and compensatory hypertrophy of cardiac myocytes (Miller, 2021, pp 1-12;
Chavey, 2000). Beta 1 receptor blockers (often referred simply as beta blockers) inhibit
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sympathetic innervation to the heart and have been shown to reduce mortality in heart failure
(Chavey, 2000).
Diagnosis and Guideline Directed Medication Therapy
There are two major guidelines established for the diagnosis and management of heart
failure, the joint presentation by the American Heart Association and the American College of
Cardiology, as well as the European Society of Cardiology publication. The AHA/ACC
guideline is considered the gold standard for the United States. The first widely used staging tool
for heart failure was created in 1964 by the New York Heart Association and classified patients
from I-IV based on subjective symptoms of cardiac disease (Table 1)(New York Heart
Association, 1964). The AHA/ACC guidelines created a supplementary staging which focused
on objective structural changes noted in heart failure from class A-D (Table 2) (Yancy et al.,
2013). Today both systems are often used simultaneously.
Recommendations for Diagnosis. The guideline emphasizes the importance on health
history and strong foundational physical assessment in diagnosis of the disease. As there is no
single diagnostic test for heart failure it is considered a clinical diagnosis, with other diagnostic
tools such as chest x-ray, echocardiogram, and standard laboratory values providing
supplementation to the clinical picture (Yancy et al., 2013). The Framingham heart failure major
criteria includes paroxysmal nocturnal dyspnea or orthopnea, neck vein distention, hepatojugular
reflex, acute pulmonary edema, rales, cardiomegaly, S3 gallop, and increased venous pressure
(McKee, Castelli, McNamara, & Kannel, 1971). Minor criteria include nocturnal cough, ankle
edema, dyspnea on exertion, hepatomegaly, and pleural effusion (McKee, Castelli, McNamara,
& Kannel, 1971).
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Recommendations for Management. The first pharmacological recommendation
discussed for all stages is the use of an angiotensin converting enzyme (ACEi) or an angiotensin
receptor blocker (ARB)(Yancy et al., 2013). After Stage A, beta blockers, aldosterone agonists,
and diuretics become key pharmacotherapy standards for the management of heart failure to
target the harmful compensatory measures previously discussed (Yancy et al., 2013). The
AHA/ACC provides various tables and flowcharts to streamline the presentation of proper
maintenance. For each category of heart failure, the guideline also provides non-pharmacologic
interventions and prompts the importance of patient education and self-care. With an admission
related to acute decompensated heart failure , it is recommended that the following management
recommendations are achieved before discharge: exacerbating factors addressed, volume status
optimized, smoking cessation completed, diuretic therapy switched to oral medications and all
IV medications be completed for at least 24 hours, ejection fraction is noted, ACEi and beta
blocker therapy is evaluated, patient and family education is completed and an outpatient follow
up appointment is scheduled (Inamdar & Inamdar, 2016).
Current Guideline Gaps. Though the AHA/ACC and ECS guidelines often make
recommendations based on high ranking level of evidence such as meta-analysis and randomized
control trials, gaps remain in the literature. Heart failure with preserved or intermediate ejection
fractions continue to have lacking individualized data with a less extensive body of evidence
when compared to HFrEF despite incidence of HFpEF being estimated at 40% of heart failure
cases (Yancy et al., 2017; Tran & Fonarow, 2014). There is also lacking consideration for
groups with potential for atypical presentation such as women and underrepresented minorities,
that are often not sufficiently included in studies (Tran & Fonarow, 2014). There is also a gap in
translation of these guidelines and recommendations into practice despite its publication. It is
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estimated that with each heart failure hospitalization an average of 3 or more medication
additions or alterations must be made to align with the recommendations established in this
guideline (Benjamin et al., 2019).
Health Disparities Within Heart Failure
Large health disparities have been noted in heart failure patients and other cardiac
conditions. Patients of African descent have a higher incidence of heart failure than any other
race in the United States and also have the worst outcomes (Nayak, Hicks, & Morris, 2020). One
contributing factor is inequity in social determinates of health such as access to healthy food and
safe areas for exercise with limited environmental hazards (Nayak, Hicks, & Morris, 2020).
Implicit bias can also effect the quality of care patients receive and lead to poor outcomes. It was
found in an analysis of over 12 million emergency department visits that patients of African
descent were less likely to be hospitalized for heart failure, even with higher acuity (Nayak,
Hicks, & Morris, 2020). Another study found that patients of African descent were less likely to
be seen by cardiology during an admission and in advanced cases were less likely to be offered
heart transplants (Nayak, Hicks, & Morris, 2020).

Heart Failure Costs
Heart failure is a costly disease with increasing prevalence and expected to increase its
large portion of the nation’s spending on healthcare. Costs primarily spur from hospital
admissions and readmissions from heart failure exacerbations. A retrospective analysis of
Medicare costs from 2005-2011 found that the average patient with heart failure cost $34,000
annually for hospitalization fees alone (Kilgore, Patel, Kielhorn, Maya, Sharma, 2017). With the
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projected costs of 160 billion dollars due to direct and indirect heart failure care and its primary
population being the elderly, CMS services has invested efforts in lowering the cost burden of
this disease (Heidenreich et al., 2013).
Purpose and Project Aims
The purpose of this project is to evaluate if the studied effects of TCM can translate and
reproduce similar effects in a heart failure transitional care pilot program in a community
hospital consisting of a network of inpatient and outpatient services. The aims of the project are
to 1.) Measure the organizations rate of heart failure readmissions and patient characteristics
before intervention. 2.) Create and implement a transitional care pilot program consisting of
three transitional care interventions. 3.) Evaluate the effects of the interventions on readmission
rates of patient participants within thirty days and determine the feasibility of the project
becoming a long-standing program.
Review of Literature
Heart Failure Readmissions
Heart failure readmissions attributes to one third of total hospital readmissions in the US
(Kilgore, Patel, Kielhorn, Maya, Sharma, 2017). The average readmission rate for heart failure
patients within 30 days is 24%, and over half when that measurement extends to 60 days (Anand,
Garg, Koene, & Thenappan, 2016). The etiology of heart failure readmission is a complex
phenomenon with multiple variables. Studies have examined the predictive factors for heart
failure readmission and findings have demonstrated that cardiac and non-cardiac comorbidities
along with the number of new medications prescribed at discharge may contribute to 30 day
readmissions (Sherer, Crane, Abel, & Efird, 2016
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Readmission Risk Stratification. Many different readmission risk identification tools
exist, yet there is no standardization in their utilization (Van Walraven et al., 2010; Sieck,
Adams, & Burkhart, 2019; Chamberlain, Sond, Mahendraraj, Lau, & Siracuse, 2018). The LACE
index, which stands for length of stay, acuity, comorbidities, and emergency department visits is
one readmission risk score which is validated and has been reported in the literature (C statistic
0.684 -Hosmer–Lemeshow goodness-of-fit statistic 14.1, p = 0.59). The LACE index uses its
naming variables to predict probability of readmission. However, the validation of this tool was
proved on a generally healthy middle- age population in Canada and has had differing success
with other age groups (Van Walraven et al., 2010). Better Outcomes by Optimizing Safe
Transitions (BOOST) project was a multi-hospital initiative to identify general risk of
readmissions for patients and provide interventions addressing these risks (0.63 95% CI, 0.610.65), (Sieck, Adams, & Burkhart, 2019). They established the “8 P’s” risk stratification tool.
The 8 P’s of predictive factors for readmission included: problems medications, psychological
factors, principal diagnosis, polypharmacy, poor health literacy, lack of patient support, prior
hospitalization, and need for palliative care (Table 3) (Sieck, Adams, & Burkhart, 2019). In 2018
the readmission after heart failure (RAHF) score was developed and validated to predict risk of
30-day readmissions specifically in heart failure patients, though widespread implementation has
yet to be seen (R²= 0.9845) (Chamberlain, Sond, Mahendraraj, Lau, & Siracuse, 2018).
CMS and Readmissions
With the affordable care act passed in 2010, the Centers for Medicare and Medicaid
Services (CMS) made a commitment to value based reimbursement verses fee for service, which
brought hospital readmissions further into light. The Hospital Readmissions Reduction Program
(HRRP) enacted reimbursement penalties to hospitals throughout an entire fiscal year based on
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excess readmissions for 6 key conditions: heart failure, acute myocardial infarctions, chronic
obstructive pulmonary disease, pneumonia, coronary bypass, and total knee and hip replacements
(Centers for Medicare and Medicaid Services, 2021). Since the implementation of the Affordable
Care Act and Subsequent HRRP program, risk adjusted heart failure readmissions decreased
over 3% and then stabilized (95% CI: 0.52% to 1.58%) (Blecker et al., 2019). In 2020, 50
percent of hospitals within HRRP program were penalized for excess readmissions, up to 3% of
expected reimbursement (Centers for Medicare and Medicaid Services, 2021). The HRRP
program evaluates key measures in heart failure care delivery for hospitals nation-wide such as
30-day readmission rate, 30-day mortality, and emergency department and observation visits
associated with a discharge (Psotka et al., 2020). While this incentive has driven value-based
care models to be adapted, it is argued that these penalties disproportionately affect hospitals that
serve communities of lower socioeconomic status and disadvantaged populations (McIlvennan,
Eapen, & Allen, 2015; Psotka et al., 2020).
Transitional Care and the Transitional Care Model
The Transitional Care Model (TCM) is one approach to ensure high quality care while
decreasing hospital re-admission rates. Developed by Mary Naylor from the University of
Pennsylvania in 1980, The TCM model uses interdisciplinary services to promote complicated
and costly patient populations during transitions of care, such as from hospital admission to
home (Naylor, 2000). Transitional care from one agency to another or from the inpatient to
outpatient care services consists of various interventions such as inpatient transitional care
provider rounding, patient targeted plans of care, discharge planning, home visits, and telephone
calls (Naylor et al., 2004).
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The TCM model has been implemented in many different care settings each discipline
having specific interventions; however, there are nine core concepts of the TCM model:
screening, staffing, maintaining relationships, engaging patients and care givers, assessing and
managing risks and symptoms, educating and promoting self-management, collaborating,
promoting continuity, and fostering coordination of care (Hirschman, Shaid, McCauley, Pauly,&
Naylor, 2015). Transitional care reinforces a culture of safety, collaboration, and patient
centered care within inpatient and outpatient services (Radhakrishnan, Jones, Weems, Knight, &
Rice, 2018).
The model has shown improvement in patient outcomes, readmission rates, hospital
costs, quality of life and management adherence (Naylor et al., 2018; Patel, Lewandowski,
Bhardwaj, Berkovitz, & Clemson, 2018; Naylor et al., 2004; Feltner et al., 2014; Wong et al.,
2016; Radhakrishnan, Jones, Weems, Knight, & Rice, 2018). One study saw a significant (
N=378 11% vs. 26%, p <0.001) reduction in readmissions for patients enrolled in a transitional
care program and a 4% reduction in 30-day mortality (Patel, Lewandowski, Bhardwaj,
Berkovitz, & Clemson, 2018). This study also experienced a 92% increase in patient
appointments in the clinic per day after transitional care providers visited patients before
discharge (Patel, Lewandowski, Bhardwaj, Berkovitz, & Clemson, 2018). Transitional care also
has benefits for patients who may not wish for heavy intervention or life saving measures. A
transitional care program for palliative care-based end stage heart failure patients saw
improvements in self-reported quality of life and a significantly decreased rate of depressive
symptoms (χ2(1, N = 68) = 1.6, p<0.05) (Wong et al., 2016).
TCM and Heart Failure Patients
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The TCM model is appropriate for the management of heart failure because it is patient
centered focusing on self-management, medication adherence, and symptom control. Studies
have found a reduction in 30- day readmission, a decrease in mortality rate, and decreased costs
for heart failure specific transitional care (Stauffer et al., 2011; Albert et al., 2015; Naylor et al.,
2004; Mai Ba, Son, Lee, & Kim, 2020; Radhakrishnan, Jones, Weems, Knight, & Rice, 2018;
Feltner et al., 2014). Transitional care has been endorsed for the treatment of heart failure
patients by the AHA (Albert et al., 2015). In a randomized control trial of 339 heart failure
patients, those who were enrolled in a three-month advanced-practice nurse discharge planning
program under the TCM model had significantly less readmissions than the control group after
52 weeks from index admission (Naylor et al., 2004). The intervention group also had lower
mean hospital associated costs by over $4,000 per admission (Naylor et al., 2004). Since this
randomized control trial, the model has been implemented to cardiac and heart failure patients
through translational studies.
An integrative review evaluating the effects of transitional care specifically on heart
failure patients found 54% of studies evaluated showed a statistically significant reduction in
heart failure readmissions, and a 67% of studies showing significant improvements in patient
quality of life from transitional care interventions (Mai Ba, Son, Lee, & Kim, 2020). One study
using physical therapists and nurses to implement transitional care in a post-acute setting
identified a 16% reduction in 30 day readmissions for heart failure patients (χ2(1, N = 462) =
13.36, p < .001) (Miller, Edenfield, Roberto, & Erb, 2017). Another 7- hospital pilot study found
that transitional care implementation was able to decrease heart failure 30-day readmission rates
to 7%, and all hospital readmission rates to 4%, well below national standards in the United
States (Radhakrishnan, Jones, Weems, Knight, & Rice, 2018). An additional meta-analysis
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evaluating 40 heart failure specific randomized control trials found heart failure specific clinics
and telephone encounter as transitional care interventions that reduced heart failure readmissions
(Feltner et al., 2014).
Operationalization of Transitional care
In an effort to increase transitional care interventions, in 2013 CMS began reimbursing
for transitional care with private insurances to follow. Providers may use specific CPT codes for
transitional care if the patient was contacted within 48 business hours after discharge and see the
patient between 7 to 14 days depending on the code used (Nicoletti, 2016). Providers are
incentivized to use complete these visits as they not only have the potential to decrease costs by
reducing readmissions but to also generate more revenue CMS offers additional reimbursement
for office visits coded under transitional care compared to established office visits with similar
level of detail (Nicoletti, 2016).
Underutilization and Limitations of Transitional Care
While transitional care is increasing in popularity due to the increasing pressures in the
last decade for tackling readmissions, it has not been implemented widespread. Underutilization
for transitional care spurs from cost concerns and limited cost analysis reported in previous
work, established culture for delivery of care, and sustainability concerns (Naylor, Mary &
Berlinger, 2016; Naylor, Mary D. et al., 2018; Stauffer et al., 2011). One study found that while
their transitional care services may have been directly more costly than standards of care, when
cost per quality adjusted life year saved were considered it was beneficial (Blum et al., 2020).
Given the complexity of heart failure as well as socio-economic and personal struggles many
heart failure patients face can also impede on the delivery of transitional care. The AHA released
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a diagram best conveying the complexity of healthcare delivery during transitions (Albert et al.,
2015)
Methodology
Project Design and Review Board Approval
The project conducted was a program evaluation with a quantitative pre- and postanalysis of a pilot program using the Transitional Care Model (TCM) to create a set of heart
failure specific transitional interventions. This project utilizes Donabedian’s Framework for
Quality Improvement to achieve these aims, focusing on changing healthcare processes to
improve outcomes (1988). Transitional care alters the process in which discharging patients
receive their care to reduce readmissions, an undesired outcome. The hospitals institutional
review board determined the project to be quality improvement in nature and the Seattle
University Institutional Review Board determined the project to exempted as “internal quality
assurance” and not human subjects’ research.
Setting and Stakeholders
This project took place within a healthcare organization with both inpatient and
outpatient services, which allowed for thorough tracking of patients through transitions of care.
The organization is the primary healthcare network for a Washington urban county with a
population of over 200,000 individuals (US Census, 2018). Need for the project arose from
recent organizational reporting’s revealed that cardiovascular conditions attributed to the highest
portion of preventable hospital stays in 2016 and reported over 400 preventable admissions
related to heart failure (Harrison, 2017). Primary stakeholders of the project included heart
failure patients in the community and the heart failure clinic staff providing the transitional care
services.
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Participants and Sampling Method
Historical data evaluated included all patients with a primary diagnosis code of heart
failure who readmitted within 30 days from January 2018-December 2019. Inclusion criteria for
the study included patient data with an appropriate diagnosis code for heart failure at time of
admission with a subsequent discharge. Exclusion criteria included data of patients who expired
before discharge of their novel admission or readmitted under end-of-life care. Using the same
inclusion and exclusion criteria, intervention data came from patient participants who underwent
transitional care from December 2020-Feburary 2021. Convenience sampling was used for
subject recruitment in the transitional care team’s work; based on participant interest and
provider availability. The program evaluation has minimal human subjects concern as it works
exclusively with deidentified data within the scope of quality improvement. The intervention of
transitional care included education and risk assessment consistent with current heart failure
treatment guidelines and evidence-based practice (Naylor et al, 2004). All patients during the
transitional care process implemented by the organization had the right to refuse the transitional
care interventions at any time.
Intervention
The three components of the transitional care team include inpatient rounding, initiation
calls, and transitional care appointments prior to discharge from the hospital. Providers from the
heart failure clinic began building rapport with patients and start risk stratification and
assessment before the patients transitioned to the outpatient care setting. Following discharge,
patients in the intervention were contacted within 48 hours for a TCM call. The TCM call was
done by either the heart failure program coordinator, a primary care clinic nurse, or the heart
failure clinic registered nurse. The TCM calls included a script of criteria recommended by

IMPLEMENTATION OF A TRANSITIONAL CARE PILOT PROGRAM

20

Family Practice Management (FPM) a subset of the American Academy of Family Physicians as
well as an additional heart failure questions developed by the organization implementing the
pilot study (Bloink, J & Adler, K, 2013). The final component of the pilot study includes
provider TCM appointments. These appointments included heart failure specific education,
reconciliation of medications, and provider recommendations for readmission prevention. The
appointments followed the TCM guidelines by FPM (Figures 1,2, & 3) (Bloink, J & Adler, K,
2013).
Data Collection and Analysis Plan
The organization’s informatics department and heart failure clinic coordinator assisted in
extracting deidentified data from the organization’s electronic health records. The average day to
readmission was assessed retrospectively for 2018-2020 before intervention. During
implementation, all heart failure admissions were assessed and tracked, and comparisons were
made between those enrolled or not enrolled in the TCM team. Key variables within the differing
groups were assessed using descriptive statistics in Microsoft Excel such as ejection fraction,
sex, and age. Days from discharge to readmission was evaluated to look at changes between the
historical data, intervention, and current standards of care (those not enrolled in program) using
an analysis of variance (ANOVA) in SPSS statistical software.
Results
Historical Data
Patient Demographics. Between 2018-2019 185 patients readmitted within 30 days and
were included in the analysis. Of the 185 patients, 41% were female and 59% male. The average
age of collected patients was 72 years old. There were slightly more patients presenting with
reduced ejection fraction (44.8%), verses preserved (40.5%) or borderline (14.6%)(Table 4).
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Information on race and ethnicity was not collected for these patients. When evaluated by each
sex, females consisted of 43% preserved ejection fraction, 15.7% borderline, and 40% reduced.
Males saw 47.7% reduced ejection fraction, 13.7% borderline, and 38.5% preserved showing
slightly differing distribution of the type of heart failure each sex was more likely to have.
Readmission Rate and Average Day to Readmission. In 2018 347 admissions were
coded under heart failure, with 80 30 day readmissions for a readmission rate of 23%. The
organization did not keep records of heart failure admissions in 2019 but based on CMS penalty
data had a similar readmission rate (US Center for Medicare and Medicaid, 2021). Within the
two years of data, patients who readmitted within 30 days on average spent 11.7 days out of the
hospital between discharge and readmission. The average day to readmittance for cardiac
readmissions was 11.3, and non-cardiac was 12.9 days. Those who attended a follow up
appointment before readmission on average stayed 14.8 days out of the hospital while those who
did not attend an appointment spent 8.8 days.
Gender and Readmission. The average day to readmission for males in 2018/2019 was
11 days, while females readmitted on average in 13 days. There was no statistically significant
difference between sex and days to readmission (t(183)=-1.27, p=0.86).
Ejection Fracture and Readmission. Ejection fracture and days to readmission was
evaluated to determine if there was any connection between the subset of heart failure and the
time it took to readmit. A linear regression showed a slightly negative, non-significant
relationship between ejection fraction and days to readmit (F(1,179)=0.469,p=0.495 B=-0.25,
R²=0.03).
Age and Readmission. Age and days to readmission was evaluated to see if there was
any connection with age of the patient and time it took to readmit. A linear regression showed a

IMPLEMENTATION OF A TRANSITIONAL CARE PILOT PROGRAM

22

slightly positive, non-significant relationship between ejection fraction and days to readmit
(F(1,182)=2.941, p=0.08, B=0.91 R²= 0.016).
Effect of post discharge appointment. Within the historical data set, attendance of a
follow up appointment was noted and tracked for every patient, however the days from discharge
this appointment took place was not assessed. were re-admitted for heart failure within 30 days of
discharge. Sixty-five patients attended a post discharge clinic visit while 95 patients did not attend
a follow-up appointment. Twenty-three patients were lost to follow-up. Attendance at a post
discharge clinic visit is associated with a 32% reduction in hospital readmission (Figure 6). For
those patients who were re-admitted, there was a statistically significant longer duration days
between discharge and re-admission for those who attended a post discharge follow up
(t(160)=5.09, p<0.001).Within those who attended a follow up appointment, there was no
significant difference from those who attended that appointment at the heart failure clinic
compared to those who saw cardiology or primary care (t(56)=.166, p=0.239).
Intervention Data
Between December 2020 and February 2021 there were 42 individuals who were
admitted with a primary diagnosis of HFrEF (76.9%) or HFpEF (17.9%) with the average age of
66 years old. Nine females and thirty three males were admitted at this time. The transitional care
pilot completed eleven inpatient rounding consults, and seven transitional care phone calls and
appointments with one patient receiving both interventions. There were ten readmissions and
three fatalities. The total readmission rate was 23.8%(Table 5).
Readmissions. Out of the 10 readmissions, eight were males and two were females. The
average number of days from discharge to readmission was 10.8 days. Only one patient from the
intervention of inpatient rounding readmitted, with 16 days out of the hospital. Nine patients
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readmitted in the non-intervention group, for a readmission rate of 36% (Figure 7) The average
days from discharge to readmission from non-intervention patients was 10.2 days. The average
ejection fraction of readmissions was 27.5. The average age of those who readmitted was 61.9.
Inpatient Rounding. Inpatient rounding was completed on 11 admissions. Out of these
patients, 1 mortality was noted and 1 readmission, giving a readmission rate of 10%. The
readmission occurred 16 days after discharge.
Transitional Care Calls and Appointments. Seven transitional care calls were
completed. Out of these admissions, no readmissions or mortalities were noted within 30 days.
Out of the completed TCM calls, there was 1 no show to the transitional care appointment and 1
appointment unsuitable for transitional care billing as it was an audio-only televisit. One
admission had both inpatient rounding as well as a transitional call and appointment.
Discussion
Implications for Practice
This project contributes to the understanding and usage for transitional care teams for heart
failure and other resource heavy diseases. The transitional care interventions appeared to show
positive impact on readmissions and mortality for those patients chosen, but a larger sample size
must be evaluated for a greater understanding of the effect on total readmissions. If a similar
reduction in readmissions were seen with an increase in scale over time this project could reduce
prevent potentially 20-30 readmissions annually. In 2019 this hospital’s average charge for heart
failure patient’s admission with an average length of stay of 2.4 days was $27,203; so these
measures could potentially save up to $816,090 and prevent financial penalties from Medicare
(Washington State Hospital Association, 2019). Transitional care may prove to be even more
impactful if other cost-burdened conditions such as chronic obstructive pulmonary disease,
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myocardial infarctions, sepsis and hip fractures were to create a standardized transition of care
model.
The lessons learned from this program will help inform future transitional care
implementation techniques. On an organizational level this pilot program has clarified important
factors addressed in the limitations section that need to be completed before a large-scale project
can be successfully implemented.
Limitations
The sample size due to a multitude of factors was significantly smaller than originally
anticipated. A stronger sample size could help determine statistical significance as well as
measure true impact the intervention have on readmissions for this communities’ patients.
Another difficulty limiting this project was scheduling patient appointments for after discharge.
Variability exists on whose responsibility it is within the organization to schedule patient
appointments for after discharge. Staff need further guidance on appropriate referrals to the heart
failure clinic verses cardiology or a primary care appointment. Availability of the providers was
also limited where transitional care appointments were attempted but could not be scheduled in
the 7-to-14 day window. This difficulty should resolve within the upcoming months as an
additional provider is added to the team.
Early on it was clear that organization is a key aspect of making a transitional care
program function appropriately. In order to do so a clinic staff must be able to manage and track
when patients are scheduled to discharge and plan ahead for clinic appointments. This was
challenging when staff had other primary responsibilities in the clinic. A nurse navigator would
provide that availability of organization and implementing the interventions.

IMPLEMENTATION OF A TRANSITIONAL CARE PILOT PROGRAM

25

Health Disparities Related to Race. A significant limitation of the project is the lack of
patient information regarding race and ethnicity. This was not a parameter mined for in both the
retrospective and intervention data. As previously discussed, large health disparities have been
noted in minorities with cardiac care. Given these key inequities, it is important for every
organization to evaluate any differences in management between races, an opportunity this
project missed.
Multiple Pilot Studies. While in the process of implementing the pilot study, other
subsets within the organizations have also made strides towards their own transitional care role
out plan. While ultimately having multiple subsets performing TCM ensures that a large number
of patients receive it, coordination must be established as only one provider may bill for TCM
per admission and multiple calls and appointments has the potential to overwhelm patients and
reduce compliance. It is a hope of the organization for these differing subsets to come together
for continuity of how to best care for these patients during transition.
Future Opportunities
In order to have a successful long term transitional care team, the limitations of the study
above must be addressed. One ideal recommendation would be the addition of a nurse navigator
to lead the program and complete the transitional calls and coordination with the patients. The
potential cost savings already discussed would allow for a location appropriate salary of this
position. For the providers, alternating weeks completing inpatient rounding and clinic time may
help continuity of care and availability. Providers schedules may be blocked in the morning for
transitional care appointment of patients who were rounded on in the hospital the week before.
Through the role out of this project and evaluation of the benefits of a strong transitional
care program can have on patients a transitional care committee for all admitting diagnoses has
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been established. This committee consists of the heart failure program coordinator, program
coordinators for sepsis and other high-risk conditions, the hospitals quality improvement team,
and representatives from the hospitalists and specialist provider teams. The transitional care
committee has also solicited the assistance of a nurse navigator from a neighboring hospital still
within the organization who has successfully implemented transitional care at two clinics in the
area.
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Appendix A: Tables
Table 1.
The New York Heart Association Classifications for Cardiac Disease (New York Heart
Association, 1964).
New York Heart Association Classification
Class

Subjective Limitations

I

Cardiac disease with no limitation

II

Cardiac disease with slight limitations with
ordinary activity, comfortable at rest

III

Cardiac disease with less than ordinary
activity limitations, comfortable at rest

IV

Cardiac disease with limitations both at rest
and with activity
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Table 2.
AHA/ACC Heart Failure Stages (Yancy et al., 2013).
AHA/ACC HF stages
Stage

Objective changes

A

At high risk for heart failure but no structural
changes in the heart

B

Structural changes with no signs or symptoms
of heart failure

C

Structural changes with current or prior signs
and symptoms of heart failure

D

Refractory heart failure requiring special
interventions
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Table 3.
The BOOST model 8 P’s of Readmissions (Sieck, Adams, & Burkhart, 2019).
The 8 Ps of Readmissions
Problem Medications

High risk medications such as digoxin,
narcotics, anticoagulants

Psychological

Diagnosis of depression or hx of

Principle Diagnosis

Key Diagnosis: cancer, stroke, diabetes, heart
failure, COPD

Polypharmacy

More than 5 routine medications

Poor Health Literacy

Inability to do teach back

Patient Support

No assistance with discharge and home care

Prior Hospitalization

Prior hospitalization within last 6 months

Palliative Care

Advanced or progressive conditions
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Table 4.
Historical Data Patient Information
Heart Failure Historical Data 2018-2019
Heart failure patients 2018

347

Heart failure patients 2019

-

30 day readmissions 2018

80

30 day readmissions 2019

105

Combined total 30 day readmissions

185

Combined % female

41%

Combined % male

59%

Combined % reduced EF

44.8%

Combined % borderline EF

14.6%

Combined % preserved EF

40.5%
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Table 5.
Intervention Group Patient Information
Intervention Data
Admissions total

42

Readmissions

10

Mortality after discharge

3

Average age

66

No intervention

25

Inpatient rounding

11 (1 patient included in both rounding and
calls/ appointments)

TCM calls/ appointments

7 (1 patient included in both rounding and
calls/ appointments)

Female

9

Male

33

% reduced

76.9%

%preserved

17.9%

% borderline

5.2%
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Appendix B: Figures
Figure 1.
Family Practice Management Recommendation for TCM call Documentation
Patient name: ______________________________________________________
Date of contact: _______ / _______ / _______
Sources of information:
Patient, family member, or caregiver (Name:
______________________________________________________________________ )
Hospital discharge summary
Hospital fax
List of recent hospitalizations or ED visits
Other:
____________________________________________________________________________
________________________________
Discharged from: ____________________________________________________ on
_______ / _______ / _______
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Diagnosis/problem:
____________________________________________________________________________
_______________________
____________________________________________________________________________
__________________________________________
Medication changes:

Yes

Medication list updated:
Needs referral or lab:

No

Yes
Yes

No
No

Needs follow-up appointment:
Within seven days of discharge (highly complex visit).
Within 14 days of discharge (moderately complex visit).
Appointment made for _______ / _______ / _______ with:
_________________________________________________________________
Additional information needed and requested:

Yes

No
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Figure 2.
Healthcare Organizations Heart Failure TCM call Script
TRANSITIONAL CARE Initial Phone Contact
Transitional Care reference article - for additional assistance
Admit date:
D/C date:
D/C from Inpatient Hospital/SNF:
Date of contact:
Family members present for conversation:
D/C Diagnoses:
Discharge Meds: (Ensure patient has update med list and has picked up prescriptions and is
taking them as prescribed.)
Med Changes (additions/discontinued) at Discharge:
Do you have the medication list from the hospital?
Do you have all the medicines at home?
Are you taking all the medicines as directed?

41
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All prescriptions have been filled, sufficient meds on hand.
Daily Weights :
Are you weighing yourself?
Are you recording your weights?
Diet:
How much sodium can you consume in a day?
Are you maintaining a low sodium diet?
Reinforced the importance to eat a low salt diet of 2GM (2000mg) per day.
Activity:
Are you getting exercise every day?
How do you feel when you exercise?
Disease Illness education/Signs and symptoms of heart failure:
Can you tell me what are signs of worsening heart failure?
When do you call the doctor?
Who do you call?

42
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Diagnostic tests reviewed:
Home health/community services/referrals coordinated:
(Review referrals tab and note to identify any referrals recommended but not placed as
orders.)
Discussions w/ other healthcare providers:
Assessment/support of treatment regimen adherence:
(Report on patient's ability to take care of ADLs and if they have adequate support to follow
the discharge care plan):
Appointments coordinated: (Identify pending appointment dates, times and clinic location
Questions, Problems or Concerns Addressed.:
Plan:
TCM f/u at HFC:
Additional f/u:
Route this note to the provider seeing the patient in follow-up.

43
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Figure 3.
Family Practice Management Recommendation for TCM Appointment Charting
For use in plan section of visit note.
Medication reconciliation:
Medication list updated
New medication list given to patient/family/caregiver
Referrals:
None needed
Referrals made to:
____________________________________________________________________________
______________________
Community resources identified for patient/family:
None needed
Home health agency
Assisted living
Hospice
Support group
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Education program:
____________________________________________________________________________
_____________________
Durable medical equipment ordered:
None needed
DME ordered:
____________________________________________________________________________
__________________________
Additional communication delivered or planned:
Family/caregiver:
____________________________________________________________________________
_______________________
Specialists:
____________________________________________________________________________
____________________________
Other:
____________________________________________________________________________
________________________________
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Patient education:
Topics discussed:
____________________________________________________________________________
_________________________

____________________________________________________________________________
__________________________________________
Handouts given:
____________________________________________________________________________
__________________________
____________________________________________________________________________
__________________________________________
____________________________________________________________________________
__________________________________________
Initial transitional care contact was made on _______ / _______ / _______ (see separate note)
FACE-TO-FACE TRANSITIONAL CARE VISIT DOCUMENTATION
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Figure 4.
Relationship Between Days from Discharge to Readmission and Ejection Fraction.
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Note: A linear regression shows a slightly negative non-significant relationship between ejection
fraction and days to readmission (F(1,179)=0.469,p=0.495 B=-0.25, R²=0.03)
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Figure 5.
Days from Discharge to Readmission and Patient Age
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Note: Linear regression showed slightly positive not statistically significant relationship between
age and days to readmission (F(1,182)=2.941, p=0.08, B=0.91 R²= 0.016).
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Figure 6.
Effect of Appointment Attendance and Days to Readmission
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Note: For those patients who were re-admitted, there was a statistically significant longer
duration days between discharge and re-admission for those who attended a post discharge
follow up (t(160)=5.09, p<0.001)
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Figure 7.
Readmission Rates for Different Intervention Groups
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